David Williams Purchases 500,000 Shares of PolyNovo Limited (ASX:PNV) Stock

PolyNovo Limited (ASX:PNVGet Rating) insider David Williams bought 500,000 shares of PolyNovo stock in a transaction dated Thursday, May 5th. The shares were acquired at an average cost of A$0.87 ($0.61) per share, with a total value of A$434,500.00 ($305,985.92).

The company has a debt-to-equity ratio of 54.21, a current ratio of 1.63 and a quick ratio of 1.07.

About PolyNovo (Get Rating)

Polynovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound.

Read More

Receive News & Ratings for PolyNovo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PolyNovo and related companies with MarketBeat.com's FREE daily email newsletter.